|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006935,
umls-concept:C0009563,
umls-concept:C0014912,
umls-concept:C0017243,
umls-concept:C0019080,
umls-concept:C0031928,
umls-concept:C0033308,
umls-concept:C0040808,
umls-concept:C0042232,
umls-concept:C0227843,
umls-concept:C0232970,
umls-concept:C0279025,
umls-concept:C0694643,
umls-concept:C1280500,
umls-concept:C1522570,
umls-concept:C1527178,
umls-concept:C1705938,
umls-concept:C2587213
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2005-6-13
|
|
pubmed:abstractText |
In a 3-year prospective study, 30 postmenopausal women received transdermal E2 gel and every-other-day vaginal P in capsules. At study completion, endometrial thickness was significantly reduced as compared with baseline (2.7 +/- 0.5 vs. 3.4 +/- 0.9 mm), endometrial biopsy showed endometrial atrophy in all cases, and amenorrhea was achieved in 92.6% of cycles, while excellent patient satisfaction was achieved.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1556-5653
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
83
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1859-63
|
|
pubmed:meshHeading |
pubmed-meshheading:15950667-Administration, Cutaneous,
pubmed-meshheading:15950667-Administration, Intravaginal,
pubmed-meshheading:15950667-Capsules,
pubmed-meshheading:15950667-Drug Administration Schedule,
pubmed-meshheading:15950667-Endometrium,
pubmed-meshheading:15950667-Estradiol,
pubmed-meshheading:15950667-Estrogen Replacement Therapy,
pubmed-meshheading:15950667-Female,
pubmed-meshheading:15950667-Humans,
pubmed-meshheading:15950667-Middle Aged,
pubmed-meshheading:15950667-Patient Compliance,
pubmed-meshheading:15950667-Pilot Projects,
pubmed-meshheading:15950667-Progesterone,
pubmed-meshheading:15950667-Prospective Studies,
pubmed-meshheading:15950667-Uterine Hemorrhage
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Endometrial effects, bleeding control, and compliance with a new postmenopausal hormone therapy regimen based on transdermal estradiol gel and every-other-day vaginal progesterone in capsules: a 3-year pilot study.
|
|
pubmed:affiliation |
1st Institute of Gynecology and Obstetrics, University of Bari, Policlinico, Piazza Giulio Cesare, Bari, Italy. cicinelli@gynecology1.uniba.it
|
|
pubmed:publicationType |
Journal Article
|
